Spriggs, M. J.

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing

Kaertner, L. S., Steinborn, M. B., Kettner, H., Spriggs, M. J., Roseman, L., Buchborn, T., Balaet, M., Timmermann, C., Erritzoe, D., & Carhart-Harris, R. L. (2021) · Scientific Reports

Psychedelics and Drug StudiesPain Management and Placebo Effect

Cited by 145

Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder

Spriggs, M. J., Kettner, H., & Carhart-Harris, R. L. (2021) · Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity

Psychedelics and Drug StudiesEating Disorders and Behaviors

Cited by 105

Psychedelics therapeutics: What we know, what we think, and what we need to research

Nutt, D., Spriggs, M., & Erritzoe, D. (2023) · Neuropharmacology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 84

Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”

Spriggs, M. J., Douglass, H. M., Park, R. J., Read, T., Danby, J. L., de Magalhães, F. J. C., Alderton, K. L., Williams, T. M., Blemings, A., Lafrance, A., et al. (2021) · Frontiers in Psychiatry

Psychedelics and Drug StudiesEating Disorders and Behaviors

Cited by 75

Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errors

Sumner, R. L., McMillan, R., Spriggs, M. J., Campbell, D., Malpas, G., Maxwell, E., Deng, C., Hay, J., Ponton, R., Sundram, F., et al. (2020) · European Neuropsychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 32